FINWIRES · TerminalLIVE
FINWIRES

Barclays Downgrades Cellectis to Underweight From Overweight, Adjusts PT to $1.30 From $9

By

Cellectis SA (CLLS) has an average rating of overweight and mean price target of $5, according to analysts polled by FactSet.

What else is happening in Research?